Pc3 cell line - OmicsDI

Show results for

Unknown (293)
Transcriptomics (249)
Genomics (152)
Proteomics (27)
Other (7)
Methylation profiling (3)

Organisms

Homo sapiens (273)
Andropogon gerardi (19)
Bacteria (19)
Canis lupus familiaris (19)
Cnidaria (19)
Cricetulus griseus (19)
Eukaryota (19)
Fasciola (19)
Hepatitis B virus (19)
Human betaherpesvirus 5 (19)
Madurella mycetomatis (19)
Mesocricetus auratus (19)
Miscanthus x giganteus (19)
Mus musculus (19)
Mycobacterium tuberculosis (19)
Orthoflavivirus (19)
Panicum virgatum (19)
Platyhelminthes (19)
Pseudomonas aeruginosa AES-1R (19)
Rattus norvegicus (19)
Rattus rattus (19)
Rhodococcus jostii RHA1 (19)
Saccharomyces cerevisiae (19)
Severe acute respiratory syndrome coronavirus 2 (19)
Shigella (19)
Sorghastrum nutans (19)
Mus musculus (15)
Canis lupus familiaris (1)
Rattus norvegicus (1)
Expression vector lentiGuide-Puro (1)

Organisms

Homo sapiens (113)
Mus musculus (3)

Repository

biostudies-arrayexpress (212)
ENA (126)
geo (71)
pride (19)
jPOST (4)
MassIVE (3)
EVA (1)
GPMDB (1)
iProX (1)
LINCS (1)

Tissue

Epithelial cell (8)
Cell culture (7)
Prostate cancer cell line (6)
Permanent cell line cell (3)
Cell line cell (2)
Epithelial cell of prostate (2)
Prostate epithelium cell line (2)
Blood serum (1)
Breast cancer cell line (1)
Colorectal cancer cell line (1)
Mammary gland cell line (1)
Prostate adenocarcinoma cell line (1)

Disease

Prostate adenocarcinoma (11)
Prostate cancer (6)
Prostate carcinoma (5)
Breast cancer (2)
Primary tumor (1)
PC-3/FGF-8b cell inoculated (1)
Cancer (1)
Glioblastoma (1)
Not Available (1)
Breast fibrocystic disease (1)

Technology Type

Mass Spectrometry (19)
Shotgun proteomics (9)
Data-dependent acquisition (4)
Affinity purification coupled with mass spectrometry proteomics (3)
Bottom-up proteomics (2)
Fluorescence intensity (1)
MEMA (1)
Affinity proteomics (1)
Chemical cross-linking coupled with mass spectrometry proteomics (1)
Data-independent acquisition (1)
Gel-based experiment (1)
SWATH MS (1)

Instrument Platform

NextSeq 500 (5)
Illumina HiSeq 2000 (4)
Illumina HiSeq 4000 (3)
G2565AA DNA microarray scanner [Agilent] (2)
Tapestri Platform (1)
IScan Illumina (1)
GenePix 4000B [Axon Instruments] (1)
Illumina NovaSeq X (1)
BGISEQ-500 (1)
NextSeq 550 (1)
Illumina HiSeq 2500 (1)
Illumina NovaSeq 6000 (1)
- (1)
Instrument (1)
Orbitrap Eclipse (1)
Orbitrap Fusion ETD (1)
Q Exactive (1)

Publication Date

2013 (43)
2014 (32)
2016 (27)
2015 (25)
2012 (25)
2011 (21)
2010 (21)
2021 (13)
2017 (13)
2019 (13)
2024 (10)
2023 (9)
2022 (9)
2026 (8)
2025 (8)
2008 (8)
2009 (7)
2020 (7)
2018 (6)
2007 (3)
2006 (2)
2005 (2)

First Public Date

2014 (29)
2024 (15)
2019 (13)
2021 (12)
2023 (11)
2020 (9)
2025 (8)
2016 (8)
2017 (6)
2022 (4)
2015 (4)
2018 (3)
2026 (2)
2013 (2)

Study type

Transcription profiling by array (138)
RNA-seq of coding RNA (15)
ChIP-seq (8)
Methylation profiling by array (8)
Other (6)
Unknown experiment type (5)
Transcription profiling by RT-PCR (4)
MicroRNA profiling by array (4)
ChIP-chip by array (3)
Comparative genomic hybridization by array (3)
Methylation profiling by high throughput sequencing (3)
ChIP-chip by tiling array (2)
Cell line - One-color microarray (2)
RNAi profiling by array (2)
MicroRNA profiling by high throughput sequencing (2)
DNA-seq (2)
Cell line - High-throughput sequencing (1)
4C (1)
RIP-seq (1)
RNA-seq of coding RNA from single cells (1)

Release Date

2013 (46)
2014 (42)
2016 (38)
2021 (35)
2015 (34)
2022 (33)
2023 (30)
2012 (29)
2010 (29)
2017 (27)
2011 (26)
2024 (24)
2020 (21)
2019 (19)
2025 (17)
2018 (17)
2009 (11)
2008 (9)
2026 (6)
2007 (5)
2006 (4)
2005 (1)
2002 (1)
1998 (1)

Lab affiliation

Aix-Marseille Université, CNRS, INSERM, Institut Paoli-Calmettes (1)
Associate Prosfessor, Johns Hopkins University, Department of Pathology Baltimore USA (1)
BK21 Plus KNU Multi-Omics based Creative Drug Research Team, College of Pharmacy, Research Institute of Pharmaceutical Sciences, Kyungpook National University, Republic of Korea (1)
BK21 Plus KNU Multi-Omics-based Creative Drug Research Team, College of Pharmacy, Research Institute of Pharmaceutical Sciences, Kyungpook National University, Republic of Korea (1)
Centre de Recherche en Cancérologie de Marseille, CRCM Inserm UMR1068, CNRS UMR7258, Aix Marseille Université U105, Institut Paoli Calmettes 27 Boulevard Leï Roure CS30059 13273 Marseille Cedex 09 France (1)
Department of Immunology, Genetics & Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden. (1)
Department of Medical Biosciences, Pathology, Umeå University, Umeå, Sweden (1)
Department of Neurosurgery, Nanfang hospital, Southern Medical University, Guangzhou 510515,China (1)
Division of Signaling and Functional Genomics, German Cancer Research Center Heidelberg Germany (1)
Faculty of Science and Engineering, Cell Biology, Åbo Akademi University, Finland (1)
Head of the Curie Institute Mass Spectrometry Platform (1)
Institute of Gene Biology, Russian Academy of Sciences, Group of Chromatin Biology (1)
Marseille Protéomique, Centre de Recherche en Cancérologie de Marseille, INSERM, CNRS, Institut Paoli-Calmettes, Aix-Marseille University, 13009 Marseille, France (1)
McGill University - Rosalind & Morris Goodman Cancer Research Centre (1)
Plant & Environmental Sciences, Breker Lab, The Hebrew University of Jerusalem, Israel (1)
Professor Loma Linda University School of Medicine, Center for Health Disparities and Molecular Medicine, 11085 Campus St, Mortensen Hall 142, Loma Linda CA 92350, USA (1)
Proteomics Platform, Broad Institute of MIT and Harvard (1)
School of Medicine Johns Hopkins University Baltimore, MD 21287, USA (1)
Università degli Studi della Campania Luigi Vanvitelli (1)

Previous page
1 / 74
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 74
Next page

Sort by:

Relevance

Page size

RNAi knock-down of EZH2 in mouse prostate cancer cell line PC3

Gene list with increasing of expression in 2-fold or more after EZH2 knockdown in PC3 cells

ORGANISM(S): Homo sapiens

2008-04-24 | E-MEXP-1581 | biostudies-arrayexpress

Inhibition of proliferation and induction of autophagy by atorvastatin in PC3 prostate cancer cells correlate with downregulation of Bcl2 and upregulation of miR-182 and p21 [miRNA expression]

The epidemiologic association between statin use and decreased risk of advanced prostate cancer suggests that statins may inhibit prostate cancer development and/or progression. Studies were performed to determine the effects of a model statin, atorvastatin (ATO), on the proliferation and different...

ORGANISM(S): Homo sapiens

2013-09-30 | E-GEOD-46375 | biostudies-arrayexpress

Effect of U94 in Gene Expression in PC3 Cells

ORGANISM(S): Homo sapiens

2010-06-10 | E-GEOD-1868 | biostudies-arrayexpress

Inhibition of proliferation and induction of autophagy by atorvastatin in PC3 prostate cancer cells correlate with downregulation of Bcl2 and upregulation of miR-182 and p21 [Gene expression]

ORGANISM(S): Homo sapiens

2013-09-30 | E-GEOD-46374 | biostudies-arrayexpress

MELK and UBE2C gene knockdown in prostate cancer cell line PC3

In order to address the putative role of MELK and UBE2C in prostate cancer development and progression, we performed functional analysis upon siRNA-based knockdown, and searched for downstream genes and processes by microarray experiments. RNAi-based inhibition of MELK and UBE2C was efficient in PC3...

ORGANISM(S): Homo sapiens

2012-10-19 | E-GEOD-32873 | biostudies-arrayexpress

Microarray analysis of PC3 prostate tumor-initiating cells (PC3 holoclones)

BACKGROUND: Cancer stem-like cells are proposed to sustain solid tumors by virtue of their capacity for self-renewal and differentiation to cells that comprise the bulk of the tumor, and have been identified for a variety of cancers based on characteristic clonal morphologies and patterns of marker ...

ORGANISM(S): Homo sapiens

2013-11-07 | E-GEOD-52161 | biostudies-arrayexpress

Siomycin A treatment in prostate cancer cell lines PC3 and LNCaP

Siomycin A treatment in prostate cancer cell lines resulted in a concurrent inhibition of specific cell cycle genes and strongly impaired cell viability. Illumina microarray experiments were done using PC3 and LNCaP cell lines treated with 0.5 microM Siomaycin A either 24h or 48h in triplicates.

ORGANISM(S): Homo sapiens

2012-10-19 | E-GEOD-36531 | biostudies-arrayexpress

Homo sapiens strain:PC3

PC3 prostate cancer cell line sequencing

PRJNA361315 | ENA

Frequent switching of Polycomb repressive marks and DNA hypermethylation in the PC3 prostate cancer cell line

Epigenetic reprogramming is commonly observed in cancer, and is hypothesized to involve multiple mechanisms, including DNA methylation and Polycomb repressive complexes (PRCs). Here we devise a new experimental and analytical strategy using customized high density tiling arrays to investigate coordi...

ORGANISM(S): Homo sapiens

2008-08-07 | E-GEOD-12334 | biostudies-arrayexpress

HOXB13 interactome in prostate cancer PC3 cell line

Transcription factors are one of the major groups of proteins whose suppression leads to tumor growth arrest. Different types of cancer express a specific set of transcription factors that establish and maintain specific gene expression patterns. In prostate cancer cells, one of the key transcriptio...

ORGANISM(S): Homo sapiens (Human)

2025-11-06 | PXD059115 | Pride

Previous page
1 / 74
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 74
Next page

Sort by:

Relevance

Page size

732 Results

Show results for

Organisms

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

First Public Date

Study type

Release Date

Lab affiliation

Tags

OmicsDI is part of the ELIXIR infrastructure

Tweets